Leukemia, B-Cell, Chronic
6 clinical trials · Condition
◉ Watch Leukemia, B-Cell, Chronic
| Record | Firm | Date |
|---|---|---|
| Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL (NCT00546793) | Gilead Sciences | 2008-01-01 |
| Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL Patients (NCT00559624) | Advancell - Advanced In Vitro Cell Technologies, S.A. | 2007-12-01 |
| Vitalis Study - Observational Study on the Quality of Life in Patients Under Treatment for B-Chronic Lymphocytic Leukemia (B-CLL) (NCT00344825) | Genzyme, a Sanofi Company | 2004-01-01 |
| Treatment of B-CLL With Human IL-2 and CD40 Ligand and Plasmid Gene Modified Autologous Tumor Cells (NCT00078520) | Baylor College of Medicine | 2003-01-01 |
Track Leukemia, B-Cell, Chronic automatically
Every clearance here is in the API, with alerts when new ones post.